AxoGen, Inc. (AXGN) VP John P. Engels Buys 4,000 Shares
AxoGen, Inc. (NASDAQ:AXGN) VP John P. Engels acquired 4,000 shares of the stock in a transaction dated Friday, October 7th. The shares were bought at an average cost of $7.50 per share, with a total value of $30,000.00. Following the completion of the transaction, the vice president now owns 98,425 shares of the company’s stock, valued at approximately $738,187.50. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website.
AxoGen, Inc. (NASDAQ:AXGN) opened at 8.72 on Monday. AxoGen, Inc. has a one year low of $4.08 and a one year high of $9.88. The firm’s market capitalization is $262.75 million. The company has a 50-day moving average price of $8.74 and a 200-day moving average price of $6.99.
AxoGen (NASDAQ:AXGN) last released its earnings results on Wednesday, August 3rd. The company reported ($0.09) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.12) by $0.03. AxoGen had a negative return on equity of 193.60% and a negative net margin of 37.90%. On average, equities research analysts anticipate that AxoGen, Inc. will post ($0.40) EPS for the current year.
A number of institutional investors have recently added to or reduced their stakes in AXGN. Waddell & Reed Financial Inc. acquired a new position in AxoGen during the second quarter valued at $1,371,000. State Street Corp acquired a new position in AxoGen during the second quarter valued at $1,885,000. Rhumbline Advisers acquired a new position in AxoGen during the second quarter valued at $132,000. Teachers Advisors Inc. acquired a new position in AxoGen during the second quarter valued at $267,000. Finally, TFS Capital LLC acquired a new position in AxoGen during the second quarter valued at $113,000. Hedge funds and other institutional investors own 57.87% of the company’s stock.
Separately, Wedbush reissued an “outperform” rating and set a $10.00 price objective (up from $9.00) on shares of AxoGen in a research report on Thursday, August 4th.
Receive News & Stock Ratings for AxoGen Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AxoGen Inc. and related stocks with our FREE daily email newsletter.